HaroldLloydKennedyMDMPH

PubMed

• Progress in Cardiac Conduction Disease and the Emergence of Artificial Intelligence in Epidemiological Research.
  Harold L Kennedy
  JACC. Advances. 2024-07-01
• 102 citations
  Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact
  Polychronis Dilaveris, Harold L. Kennedy
  Clinical Cardiology. 2017-06-01
• 35 citations
  Interspecific hybridization causes long-term phylogenetic discordance between nuclear and mitochondrial genomes in freshwater fishes.
  Graham P. Wallis, Sophia R. Cameron-Christie, Hannah L. Kennedy, Gemma Palmer, Tessa R. Sanders
  Molecular Ecology. 2017-06-01

Journal Articles

• Silent Atrial Fibrillation: Definitions, clarification,and unanswered issues  
  Kennedy HL, Ann Noninvasive Electrocardiol, 1/1/2015
• Shlomo Stern (1928-2013)- visionary leader with great legacy in memoriam  
  Hombach V, Kennedy HL, Moss AJ, Bayes de Luna A, Zareba W, Ann Noninvas Electrocard, 1/1/2013
• Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure  
  Abrahamsson P, Dobson J, Granger CB, and CHARM Investigators, Europ Heart J, 1/1/2009
• Intracoronary nitroglycerin and regional coronary blood flow responses during coronary angioplasty in patients  
  Kern MJ, Vandormael M, Deligonul U, Labovitz A, Harper M, Gibson P, Presant S, Kennedy HL, J of Intervent Cardiol, 1/1/2007
• The effects of coronary angioplasty on nitroglycerin- induced augmentation of regional myocardial blood flow  
  Kern MJ, Presant S, Deligonul U, Vandormael M, Kennedy HL, J of Intervent Cardiol, 1/1/2007
• Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure  
  O’Meara E, Clayton T, McEntegart MC, and CHARM Investigators, Circulation, 1/1/2007
• Red cell distribution width as a novel prognostic marker in Heart failure  
  Felker GM, Allen LA, Pocock SJ, and CHARM Investigators, J Am Coll Cardiol, 1/1/2007
• Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure  
  Solomon SD, Dobson J, Pocock S, and CHARM Investigators, Circulation, 1/1/2007
• Incidence and predictors of hyperkalemia in patients with heart failure  
  Desai AS, Swedberg K, McMurray JJV, and CHARM Investigators, J Am Coll Cardiol, 1/1/2007
• Body mass index and prognosis in patients with chronic heart failure  
  Kenchaiah S, Pocock SJ, Wang D, and CHARM Investigators, Circulation, 1/1/2007
• The history,science and innovation of Holter technology  
  Kennedy HL, Ann Noninvas Electrocardiol, 1/1/2006
• Renal function s a predictor of outcome in a broad spectrum of patients with heart failure  
  Hillege HL, Nitsch D, Pfeffer MA, and CHARM Investigators, Circulation, 1/1/2006
• Cryptogenic stroke and migraine headache: The clinical cardiologist’s viewpoint  
  Kennedy HL, Hospital Chronicle, 1/1/2006
• Predictors of mortality and morbidity in patients with chronic heart failure  
  Pocock SJ, Wang D, Pfeffer MA, and CHARM Investigators, Europ Heart J, 1/1/2006
• Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesart in Heart Failure: Assesment of reduction in mortal...  
  Ducharme A, Swedberg K, Pfeffer MA, and CHARM Investigators, Am Heart J, 1/1/2006
• Clinical correlates and consequences of anemia in a broad Spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assesment of reduction ...  
  O’Meara E, Clayton T, McEntegart MB,and CHARM Investigators, Circulation, 1/1/2006
• Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomized controlled clinical trial  
  Granger BB, Swedberg K, Ekman I, and CHARM Investigators, Lancet, 1/1/2005
• Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients  
  Solomon SD, Anavekar N, Skali H, and CHARM Investigators, Circulation, 1/1/2005
• Efficacy,safety and tolerability of Beta-adrenergic blockade with Metoprolol CR/XL in elderly patients with heart failure  
  Deedwania PC, Gottlieb S, Ghali JK, MERIT-HF Study Group, Europ Heart J, 1/1/2004
• Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction  
  Young JB, Dunlap ME, Pfeffer MA, and CHARM Investigators, Circulation, 1/1/2004
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme  
  Pfeffer MA, Swedberg K, Granger CB, the CHARM Investigators, Lancet, 1/1/2003
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM...  
  McMurray JJV, Ostergren J, Swedberg K, the CHARM Investigators, Lancet, 1/1/2003
• Metoprolol CR/XL in black patients with heart failure  
  Goldstein S, Deedwania P, Gottlieb S, MERIT-HF Study Group, Am J Cardiol, 1/1/2003
• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: th...  
  Granger CB, McMurray JJV, Yusuf S, the CHARM Investigators, Lancet, 1/1/2003
• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial  
  Yusuf S, Pfeffer MA, Swedberg K, the CHARM Investigators, Lancet, 1/1/2003
• Join now to see all

Books/Book Chapters

• Cardiology Update 2004 
  Chapter: HOPE and EUROPA: Optimal anti-ischemic therapy 
  Kennedy HLEditors: Manolis A..EBAC Press, Athens, Greece2004
• Cardiac Electrophysiology – From Cell to Bedside 
  Chapter: Long-Term (Holter) Electrocardiography 
  Kennedy HLEditors: Zipes DP, Jalife J.W.B. Saunders Co., Philadelphia, PAEdition 4th,2003
• Benign Ventricular Ectopic Activity: Evolving Insights 
  Chapter: Cardiac Electrophysiology Review 
  Kennedy HLEditors: Anderson KA.Kluwer Academic Publishers, Boston, MA2001
• Cardiac Electrophysiology –From Cell to Bedside 
  Chapter: Use of the Long-Term Electrocardiogram 
  Kennedy HLEditors: Zipes DP, Jalife J..W.B. Saunders Co., Philadelphia, PAEdition 3rd,2000
• Cardiac Electrophysiology Review 
  Page 90 - 91Kennedy HLKluwer Academic Publishers, Boston, MA1997
• Overview of the Management of Acute MI 
  Reeder RS, Kennedy HL, Rosenson RSEditors: Rose B.UpToDate Publications, Wellesley, MA1996
• Beta-blockers in Acute Myocardial Infarction 
  Rosenson RS, Reeder GS, Kennedy HLUpToDate Publications, Wellesley, MA1996
• Handbook of Cardiac Arrhythmia 
  Chapter: Holter Monitoring 
  Page 1 - 6Kennedy HLEditors: Podrid PJ, Kowey PR.Williams & Wilkins, Philadelphia, PA1996
• Heart Rate Variability 
  Chapter: Heart rate variability instruments from commercial manufacturers 
  Page 127 - 132Kennedy HLEditors: Malik M, Camm AJ.Futura Publ1995
• Role of Holter Monitoring for arrhythmia (bradyarrhythmia and tachyarrhythmia) assessment and management 
  Page 219 - 232Kennedy HLEditors: Podrid PJ and Kowey PR.Williams & Wilkins, Philadelphia, PA1995
• Cardiac Electrophysiology - From Cell to Bedside 
  Chapter: Ambulatory (Holter) electrocardiography recordings 
  Page 1024 - 1037Kennedy HLEditors: Zipes DP, Jalife J.W.B. Saunders Co, Philadelphia, PAEdition 2nd,1995
• Quick Reference To Internal Medicine 
  Chapter: Approach to the patient with cardiovascular disease 
  Kennedy HLEditors: Bone RC.Igaku-Fhoin Medical Publishers Inc.1994
• Ambulatory Electrocardiography - Current Clinical Concepts 
  Chapter: Cardiology Clinics 
  Kennedy, HLW.B. Saunders, Philadelphia, PA1992
• Cardiology 
  Chapter: Ambulatory Holter electrocardiography: Technology, clinical applications, and limitations 
  Page 87 - 99Morganroth J, Kennedy HLEditors: Chatterjee AK, Cheitlin MD, Karliner JS, Parmley WW, Rapaport E, Scheinman MM.J.B. Lippincott Co / Gower Medical Publishers, Mutiple Locations1992
• 10th International Congress of the New Frontiers of Arrhythmias 
  Chapter: Ambulatory (Holter) electrocardiography signal-averaging: Techniques, applications, and limitations 
  Page 19 - 36Kennedy HL, Bavishi NSEditors: John Libby and Sons, Ltd..John Libby and Sons, Ltd., Rome, Italy1992
• Silent Myocardial Ischemia: A Critical Appraisal 
  Chapter: Silent myocardial ischemia after coronary artery bypass graft surgery 
  Page 261 - 269Kennedy HLEditors: Kellerman JJ, Braunwald EG.Adv Cardiol. Basal, Karger1990
• Cardiac Electrophysiology - From Cell to Bedside 
  Chapter: Long-term (Holter) electrocardiographic recording 
  Page 791 - 797Kennedy HLEditors: Zipes DP, Jalife J.W.B. Saunders Co, Philadelphia, PAEdition 1st,1990
• Electrocardiography and Cardiac Drug Therapy 
  Chapter: Holter ECG and the diagnosis of cardiac arrhythmias 
  Page 58 - 78Kennedy HL, Wiens RDEditors: Hombach V, Hilger HH, Kennedy HL.Kluwer Academic Publishers, The Neatherlands1989
• Electrocardiography and Cardiac Drug Therapy 
  Hombach V, Hilger HH, Kennedy HLKluwer Academic Publishers, The Neatherlands1989
• Progress in Cardiology 
  Chapter: Long-term (Holter) electrocardiogram recordings 
  Kennedy HLEditors: Zipes DP, Desmond J.Lea & Febiger, Philadelphia, PA1988
• Silent Myocardial Ischemia 
  Chapter: Methods to detect ischemia using ambulatory (Holter) electrocardiography 
  Kennedy HLEditors: Morganroth J, Moore EN.Kluwer Academic Publishers, Boston, MA1988
• Sudden Cardiac Death 
  Chapter: Exercise testing and ambulatory electrocardiography in normals and in patients at risk of sudden cardiac death 
  Buckingham TA, Kennedy HLEditors: Morganroth J, Horowitz L.Grune & Stratton, New York, NY1985
• Ambulatory Blood Pressure Monitoring 
  Chapter: Ambulatory blood pressure in 199 normal subjects, a collaborative study 
  Wallace JM, Thornton WE, Kennedy HL, Pickering TG, Harshfield GA, Frohlich ED, Messerli FH, Gifford RW, Bolen KEditors: Weber MA, Drayer JIM.Springer-Verlag, New York, NY1984
• Cardiology volume 3 Cardiovascular Problems of the Adolescent and Young Adult 
  Chapter: Normal ambulatory electrocardiogram of the adolescent or young adult 
  Kennedy HLEditors: Julian DG, Wenger NK.Butterworth and Co. Ltd., London, England1984
• International Symposium on Holter Monitoring Technique 
  Chapter: The historical and future development of the Holter EKG technique 
  Kennedy HL, Wiens RDEditors: Hombach V, Hilger HH. F.K. Schattauer.Verlag, Stuttgart, New York, NY1983
• Join now to see all

Abstracts/Posters

• Electrocardiographic diagnosis made by General Cardiologists
  Dubner S, Moss A, Zareba W, Mautner B, Oto A, Bayes de Luna A, Kennedy H, Europace, 1/1/2004
• Cardiovascular diseases and outcomes associated with sleep apnea syndromes
  Kennedy HL, Europace, 1/1/2002
• Beta-blockers in congestive heart failure: an evidence-based viewpoint
  Kennedy HL, Journal Sociedade Portugues de Cardiologia, 1/1/1998
• QT dispersion in congestive heart failure and effects of chronic beta-blocker therapy (MERIT-HF Pilot Study)
  Kennedy HL, Goldstein S, Gottlieb S. Gheorghiade M, Jessup M, Karlsberg R, Anderson J, Friday G, Haskell L, Arch Coeur Vaisseaux, 1/1/1998
• Improvement in QT dispersion with selective vs non-selective B-blockade in patients with dilated cardiomyopathy
  Fesmire SL,Eichhorn EJ, Kennedy HL, Marcoux LG, Lyyski DS, Sprague MK, Europ heart J, 1/1/1998
• Extended release metoprolol in the treatment of heart failure
  Kennedy HL, Anderson J, Gheorghiade M, Goldstein S, Gottlieb S, Jessup M, Karlsberg R, J Heart Failure, 1/1/1997
• Nonsustained ventricular tachycardia in congestive heart failure and beta-blocker therapy
  Kennedy HL, Goldstein S, Gottlieb S. Gheorghiade M, Jessup M, Karlsberg R, Anderson J, Friday G, Haskell L. MERIT-HF Pilot Study, Europ Heart J, 1/1/1997
• Inaccuracy of Holter Analysis in Detecting and Quantitating Non-Sustained Ventricular Tachycardia in the Cardiac Arrhythmia Suppression Trial (CAST)
  Kennedy HL, Morris M, Brooks MM for the CAST Investigators, Europ Heart J, 1/1/1995
• Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I)
  Pitt B, Mancini JG, Ellis SG, Rosman HS, McGovern ME for the PLAC I Investigators, J Am Coll Cardiol, 1/1/1994
• Ventricular arrhythmias and mortality after myocardial infarction: A follow-up study of 14,534 patients in the CAST Holter registry
  Hodges M, Denes P, Morris MM, Hallstrom AP for the CAST Investigators, J Am Coll Cardiol, 1/1/1994
• Gender differences in circadian pattern of transient ischemic episodes in asymptomatic and minimally symptomatic patients with CAD
  Deedwania PC, Pepine CJ, Thadani U, Marks R, Handberg E for the ASIST Study Group, J Am Coll Cardiol, 1/1/1994
• Absence of morning increase in transient ischemia in survivors of acute myocardial infarction
  Deedwania PC, Pepine CJ, Cohn PF, Marks R, Handberg E for the ASIST Study Group, J Am Coll Cardiol, 1/1/1994
• Holter "triage" ambulatory ECG analysis - is it accurate?
  Kennedy HL, Lyyski DS, Sprague MK, J Ambul Monit, 1/1/1994
• ßeta-blocker therapy and congestive heart failure in the Cardiac Arrhythmia Suppression Trial (CAST)
  Kennedy HL, Goldstein S, Barker AH, Brooks MM, Huther ML, Beanlands DS, Bigger JT, Bergstrand R, and the CAST Investigators, J Am Coll Cardiol, 1/1/1993
• Is there a relationship between ejection fraction and moricizine mortality in the Cardiac Arrhythmia Suppression Trial (CAST)
  Chahine RA, Morganroth J, Bigger JT, Hallstrom AP, for the CAST Investigators, J Am Coll Cardiol, 1/1/1993
• Prognostic significance of SAECG after thrombolysis in acute myocardial infarction (Cardiac Arrhythmia Suppression Trial (CAST)
  Denes P, El-Sherif NE, Katz RJ, Wyse DG, Capone RJ, Reynolds-Haertle R, for the CAST Investigators, J Am Coll Cardiol, 1/1/1993
• Smoking cessation and arrhythmic death: The CAST experience
  Peters RW, Todd L, Brooks MM, Liebson PR, Wilhelmsen L for the CAST Investigators, Circulation, 1/1/1993
• Increased onset of acute myocardial infarction on Monday
  Peters RW, Zoble RG, Brooks MM, Liebson PR, Barker A, Seals AA for the CAST Investigators, Circulation, 1/1/1993
• Evidence that participation in a randomized clinical trial has an inherently beneficial effect on survival
  Hallstrom AP, Denes P, Morris M for the CAST Investigators, Circulation, 1/1/1993
• Therapy adherence and mortality in the Cardiac Arrhythmia Suppression Trial
  Obias Manno D, Friedmann E, Brooks MM, Thomas SA, Haakenson C, Somelofski C, Johnson M, Jared L, Goldner F, Wimbush F, Harrison J, Morris M, and the CAST Investigators, Controlled Clin Trials, 1/1/1993
• What time period during ambulatory (Holter) ECG should be used for the signal-averaged ECG?
  Kennedy HL, Lyyski DS, Sprague MK, Seiler SM, Uretz EF, Bavishi NS, J Ambul Monit, 1/1/1992
• Analysis of early ventricular proarrhythmia in the Cardiac Arrhythmia Suppression Trial (CAST)
  Wyse GD, Morganroth J, Hallstrom AP, and the CAST Investigators, J Am Coll Cardiol, 1/1/1992
• Long-term suppression of ventricular arrhythmia in the Cardiac Arrhythmia Suppression Trial (CAST)
  Salerno DM, Hallstrom AP, Pratt CM, and the CAST Investigators, J Am Coll Cardiol, 1/1/1992
• Failure of treatment with moricizine to improve survival in a randomized trial of arrhythmia suppression after myocardial infarction: The Cardiac Arrhythmia Suppressio...
  The CAST Investigators, J Am Coll Cardiol, 1/1/1992
• Lethal and non-lethal events (moricizine versus encainide/flecainide) in the CAST I and CAST II
  Hallstrom AP, Kammerling JM, Duff HJ, and the CAST Investigators, J Am Coll Cardiol, 1/1/1992
• Join now to see all

Lectures

• Silent Atrial Fibrillation: Definition, Clarification, and Unanswered Issues 
  Lyon, France - 1/4/2015
• Evolution of Ambulatory ECG Monitoring - The Smartphone 
  Timisoara, Romania - 1/30/2013
• Sudden cardiac death – a changing perspective 
  Yokohama, Japan - 1/3/2009
• Advances in Heart Failure 
  Long Beach, CA - 1/24/2008
• Holter Monitoring 50 years after Norman Holter: towards a comprehensive non-invasive electrophysiological test 
  Athens, Greece - 1/8/2007
• Is QRS duration sufficient to qualify patients for CRT? 
  Nice, France - 1/18/2004
• HOPE and EUROPA. Optimal anti-ischemic therapy as indicated by newer data from the HOPE and EUROPA trials 
  Athens, Greece - 1/15/2004
• Sleep disordered breathing and cardiovascular disease 
  Chicago,IL - 1/29/2003
• Arterial Hypertension 
  Rio de Janeiro, Brasil - 1/22/2003
• ICD – Primary prevention of sudden death 
  Tokyo, Japan - 1/7/2003
• Antiarrhythmic therapy in coronary artery disease 
  Patras, Greece - 1/27/2002
• The role of B-blockers in coronary artery disease 
  Patras, Greece - 1/26/2002
• Cardiovascular diseases and outcomes associated with sleep apnea syndromes 
  Nice, France - 1/19/2002
• Diagnostic methods of sleep apnea syndromes..Is there a role for Holter recording methods? 
  Nice, France - 1/19/2002
• Silent myocardial ischemia: Perspective in 2001 
  Guaruja, Sao Paulo, Brasil - 1/29/2001
• Importance of interpreting randomized clinical trials 
  Bozeman, MT - 1/15/2001
• Risk factors for heart failure 
  Istanbul, Turkey - 1/25/2000
• Clincal decision making in cardiac arrhythmia 
  Bangkok, Thialand - 1/17/2000
• Ventricular arrhythmias without obvious structural heart disease 
  Bangkok, Thailand - 1/17/2000
• Holter State-of-the-Art 
  Vienna, Austria - 1/4/2000
• Heart failure in ischemic cardiomyopathy – Therapy, state of the art 
  Athens,Greece - 1/28/1999
• Atrial fibrillation in heart failure 
  Buenos Aires, Argentina - 1/24/1999
• Ventricular arrhythmias in ischemic heart disease 
  Buenos Aires, Argentina - 1/22/1999
• Treatment of malignant ventricular arrhythmias 
  Buenos Aires, Argentina - 1/21/1999
• Causes of sudden cardiac death – A clinical perspective 
  Hong Kong, Taiwan - 1/18/1999
• Join now to see all